Immunization and MS: A summary of published evidence and recommendations

Neurology

Volumn 59, Issue 12, 2002, Pages 1837-1843

  Rutschmann, Olivier T ^a,b   McCrory, Douglas C ^a   Matchar, David B ^a   Bourdette, Dennis ^c   Copperman, Lois ^c   Coyle, Patricia ^d   DeStafano, Frank ^e   Marrie, Thomas ^f   Miller, Deborah ^g   Phair, Cindy ^h   Richert, John ⁱ   Goodin, Douglas S ^b   Armon, Carmel ^b   Frohman, Elliot M ^b   Goldman, Robert S ^b   Hammond, David ^b   Hsu, Chung Y ^b   Kanner, Andres M ^b   Lefkowitz, David S ^b   Silverman, Isaac E ^b   Sloan, Michael A ^b   So, Yuen T ^b   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b AMERICAN ACADEMY OF NEUROLOGY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g LERNER RESEARCH INSTITUTE   (United States)

^h Multiple Sclerosis Treatment/Res Ctr   (United States)

ⁱ GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; TYPHOID VACCINE;

ARTICLE; CHICKENPOX; DISEASE EXACERBATION; DRUG SAFETY; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; MULTIPLE SCLEROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TETANUS; TUBERCULOSIS;

EID: 0037168795     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.12.1837     Document Type: Article

References (29)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-952.
2. Poser CM. Notes on the pathogenesis of multiple sclerosis. Clin Neurosci 1994;2:258-265.
3. Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A. Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study. J Neurol 1993;240: 417-422.
4. Panitch HS, Bever CT, Katz E, Johnson KP. Upper respiratory tract infections trigger attacks of multiple sclerosis in patients treated with interferon. J Neuroimmunol 1991;36: 125.
5. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985;1:1313-1315.
6. Narod S, Johnson-Lussenburg CM, Zheng Q, Nelson R. Clinical viral infections and multiple sclerosis. Lancet 1985;ii:165-166.
7. Gay D, Dick G, Upton G. Multiple sclerosis associated with sinusitis: Case-controlled study in general practice. Lancet 1986;1:815-819.
8. Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64:736-741.
9. Panitch HS. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 1994;36(suppl):S25-S28.
10. Sibley WA, Foley JM. Infection and immunization in multiple sclerosis. Ann NY Acad Sci 1965;122:457-468.
11. De Keyser J, Zwanikken C, Boon M. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci 1998;159:51-53.
12. Ristori G, Buzzi MG, Sabatini U, et al. Use of Bacille Calmette-Guerin (BCG) in multiple sclerosis. Neurology 1999;53:1588-1589.
13. Riikonen R. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children. Acta Neurol Scand 1989;80:425-431.
14. Quast U, Herder C, Zwisler O. Vaccination of patients with encephalomyelitis disseminata. Vaccine 1991;9:228-230.
15. Miller H, Cendrowski W, Shapira K. Multiple sclerosis and vaccination. BMJ 1967;2:210-213.
16. Ono F. Possible relation of small pox vaccination to multiple sclerosis-like disease. A personal note. Med Hypotheses 1986; 20:339-340.
17. Ross RT, Nicolle LE, Cheang M. The varicella zoster virus: a pilot trial of a potential therapeutic agent in multiple sclerosis. J Clin Epidemiol 1997;50:63-68.
18. Ross RT. Varicella and remission of multiple sclerosis. Lancet 1991;337:300.
19. Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 2001;344:319-326.
20. Miller AE, Morgante LA, Buchwald LY, et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 1997;48:312-314.
21. Mokhtarian F, Shirazian D, Morgante L, Miller A, Grob D, Lichstein E. Influenza virus vaccination of patients with multiple sclerosis. Mult Scler 1997;3:243-247.
22. Myers LW, Ellison GW, Lucia M, et al. Swine influenza virus vaccination in patients with multiple sclerosis. J Infect Dis 1977;136 (suppl):S546-54.
23. Bamford CR, Sibley WA, Laguna JF. Swine influenza vaccination in patients with multiple sclerosis. Arch Neurol 1978;35: 242-243.
24. Salvetti M, Pisani A, Bastianello S, Millefiorini E, Buttinelli C, Pozzilli C. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination. J Neurol 1995;242:143-146.
25. Salvetti M, Pisani A, Bastianello S, Millefiorini E, Buttinelli C, Pozzilli C. Influenza immunization in multiple sclerosis. Neurology 1997;49:1474-1475.
26. Sibley WA, Bamford CR, Laguna JF. Influenza vaccination in patients with multiple sclerosis. JAMA 1976;236:1965-1966.
27. Kurland LT, Molgaard CA, Kurland EM, Wiederholt WC, Kirkpatrick JW. Swine flu vaccine and multiple sclerosis. JAMA 1984;251:2672-2675.
28. Michielsens B, Wilms G, Marchal G, Carton H. Serial magnetic resonance imaging studies with paramagnetic contrast medium: Assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination. Eur Neurol 1990;30:258-259.
29. Anonymous. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(RR03):1-38.